Zhao D, et al. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2019;16(4):203–12.

Article  PubMed  Google Scholar 

Kivimäki M, Steptoe A. Effects of stress on the development and progression of cardiovascular disease. Nat Rev Cardiol. 2018;15(4):215–29.

Article  PubMed  Google Scholar 

Li Z, et al. Targeted anti-IL-1β platelet microparticles for cardiac detoxing and repair. Sci Adv. 2020;6(6):eaay0589.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ikonomidis I, et al. Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis. Circulation. 2008;117(20):2662–9.

Article  CAS  PubMed  Google Scholar 

Nakano A, et al. Cytokine gene therapy for myocarditis by in vivo electroporation. Hum Gene Ther. 2001;12(10):1289–97.

Article  CAS  PubMed  Google Scholar 

Yamada T, Matsumori A, Sasayama S. Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by Encephalomyocarditis virus. Circulation. 1994;89(2):846–51.

Article  CAS  PubMed  Google Scholar 

Szalay G, et al. Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders. Am J Pathol. 2006;169(6):2085–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaur K, et al. Biology of TNFalpha and IL-10, and their imbalance in heart failure. Heart Fail Rev. 2009;14(2):113–23.

Article  CAS  PubMed  Google Scholar 

Yuan X, et al. Editorial: Purinergic Signaling and inflammation. Front Immunol. 2021;12:699069.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zindel J, Kubes P. DAMPs, PAMPs, and LAMPs in immunity and sterile inflammation. Annu Rev Pathol. 2020;15:493–518.

Article  CAS  PubMed  Google Scholar 

Marchi S, et al. Mitochondrial control of inflammation. Nat Rev Immunol. 2023;23(3):159–73.

Article  CAS  PubMed  Google Scholar 

Garg M, Johri S, Chakraborty K. Immunomodulatory role of mitochondrial DAMPs: a missing link in pathology? Febs j. 2023;290(18):4395–418.

Article  CAS  PubMed  Google Scholar 

Vringer E, Tait SWG. Mitochondria and cell death-associated inflammation. Cell Death Differ. 2023;30(2):304–12.

Article  CAS  PubMed  Google Scholar 

Bock FJ, Tait SWG. Mitochondria as multifaceted regulators of cell death. Nat Rev Mol Cell Biol. 2020;21(2):85–100.

Article  CAS  PubMed  Google Scholar 

Nicholls TJ, Gustafsson CM. Separating and segregating the human mitochondrial genome. Trends Biochem Sci. 2018;43(11):869–81.

Article  CAS  PubMed  Google Scholar 

Xian H, et al. Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling. Immunity. 2022;55(8):1370–e13858.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alam K, Moinuddin, Jabeen S. Immunogenicity of mitochondrial DNA modified by hydroxyl radical. Cell Immunol. 2007;247(1):12–7.

Article  CAS  PubMed  Google Scholar 

Pazmandi K, et al. Oxidative modification enhances the immunostimulatory effects of extracellular mitochondrial DNA on plasmacytoid dendritic cells. Free Radic Biol Med. 2014;77:281–90.

Article  CAS  PubMed  Google Scholar 

Ishikawa K, et al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science. 2008;320(5876):661–4.

Article  CAS  PubMed  Google Scholar 

Kujoth GC, et al. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science. 2005;309(5733):481–4.

Article  CAS  PubMed  Google Scholar 

McArthur K et al. BAK/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis. Science, 2018. 359(6378).

Riley JS et al. Mitochondrial inner membrane permeabilisation enables mtDNA release during apoptosis. Embo j, 2018. 37(17).

Patrushev M, et al. Release of mitochondrial DNA fragments from brain mitochondria of irradiated mice. Mitochondrion. 2006;6(1):43–7.

Article  CAS  PubMed  Google Scholar 

Kim J, et al. VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease. Science. 2019;366(6472):1531–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang LS, et al. mtDNA activates cGAS Signaling and suppresses the YAP-Mediated endothelial cell Proliferation Program to Promote Inflammatory Injury. Immunity. 2020;52(3):475–e4865.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sliter DA, et al. Parkin and PINK1 mitigate STING-induced inflammation. Nature. 2018;561(7722):258–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rodríguez-Nuevo A et al. Mitochondrial DNA and TLR9 drive muscle inflammation upon Opa1 deficiency. Embo j, 2018. 37(10).

Bueno M, et al. PINK1 attenuates mtDNA release in alveolar epithelial cells and TLR9 mediated profibrotic responses. PLoS ONE. 2019;14(6):e0218003.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ishikawa H, Barber GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature. 2008;455(7213):674–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rongvaux A, et al. Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA. Cell. 2014;159(7):1563–77.

Article  CAS  PubMed  PubMed Central  Google Scholar 

White MJ, et al. Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production. Cell. 2014;159(7):1549–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477–89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xian H, et al. Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation. Immunity. 2021;54(7):1463–e147711.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhong Z, et al. New mitochondria